Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
本文档由 200ddca5bc 分享于2020-05-28 08:51
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~